Meropenem and Sepsis neonatal - a phase IV clinical study of FDA data

Summary:

Sepsis neonatal is reported as a side effect among people who take Meropenem (meropenem), especially for people who are male, 0-1 old, also take Cefotaxime, and have Acute kidney failure.

The phase IV clinical study analyzes which people have Sepsis neonatal when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Sepsis neonatal?

Sepsis neonatal (a bacterial infection in the blood. it is found in infants during the first month of life) is found to be associated with 116 drugs and 202 conditions by eHealthMe. Check the latest studies of Sepsis neonatal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

33,250 people reported to have side effects when taking Meropenem.
Among them, 14 people (0.04%) have Sepsis neonatal.

Could Meropenem cause Sepsis neonatal?

Among these 14 people:

What is the gender of people who have Sepsis neonatal when taking Meropenem? *

  • female: 45.45 %
  • male: 54.55 %

What is the age of people who have Sepsis neonatal when taking Meropenem? *

  • 0-1: 100 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Meropenem? *

  1. Vancomycin: 4 people, 28.57%
  2. Cefotaxime: 4 people, 28.57%
  3. Vancomycin Hcl: 2 people, 14.29%
  4. Gentamicin Sulfate: 2 people, 14.29%
  5. Erythromycin: 2 people, 14.29%
  6. Ceftriaxone: 2 people, 14.29%
  7. Vancomycin Hydrochloride: 1 person, 7.14%
  8. Magnesium: 1 person, 7.14%
  9. Levofloxacin: 1 person, 7.14%
  10. Hydrocortisone: 1 person, 7.14%

What are other side effects people have besides Sepsis neonatal? *

  1. Premature Baby: 7 people, 50.00%
  2. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 7 people, 50.00%
  3. Stenotrophomonas Infection: 4 people, 28.57%
  4. Fatigue (feeling of tiredness): 4 people, 28.57%
  5. Hypotonia Neonatal (low muscle tone in neonatal): 4 people, 28.57%
  6. Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 28.57%
  7. Umbilical Erythema (redness at umbilical site): 4 people, 28.57%
  8. Pneumonia Bacterial (pneumonia associated with bacterial infection): 3 people, 21.43%
  9. Drug Ineffective: 3 people, 21.43%
  10. Neonatal Pneumonia (lung infection in a neonate): 3 people, 21.43%

What are the existing conditions these people have? *

  1. Stenotrophomonas Infection: 4 people, 28.57%
  2. Respiratory Tract Infection: 4 people, 28.57%
  3. Acute Kidney Failure: 4 people, 28.57%
  4. Trichosporon Infection (a fungal infection by trichophyton): 3 people, 21.43%
  5. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 2 people, 14.29%
  6. Urinary Tract Infection: 1 person, 7.14%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 7.14%
  8. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 7.14%
  9. Neonatal Pneumonia (lung infection in a neonate): 1 person, 7.14%
  10. Neonatal Infection (infection to neonate): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Sepsis neonatal?

- Check whether Sepsis neonatal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meropenem:

Sepsis neonatal treatments and more:

How severe was Sepsis neonatal and when was it recovered:

Expand to all the drugs that have ingredients of meropenem:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis neonatal:

Browse all the conditions that are associated with Sepsis neonatal:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: